Company profile: Aptamer Group
1.1 - Company Overview
Company description
- Provider of DNA and RNA aptamer technologies, developing Optimer next-generation binders for R&D, diagnostics and therapeutics. Offerings include custom Optimer selection, bioprocessing capture reagents for purification and QC, therapeutics and conjugates for targeted delivery, assay and diagnostic reagents (IHC, ICC, biosensors, LFD, ELISA, flow cytometry), and single-reagent Optimer Beacons.
Products and services
- Optimer® Selection and Development Services: Custom-engineered selection and development of Optimer® binders—short DNA/RNA aptamers—with high-affinity, target specificity for therapeutics, diagnostics, and research applications across virtually all target types
- Optimer® for Assays and Diagnostics: Multi-format Optimer® binders enable specific target detection and quantification in IHC, ICC, biosensors, LFD tests, ELISA, and flow cytometry, leveraging high-affinity DNA/RNA aptamer interactions
- Optimer® Therapeutics: Mechanism-specific Optimer® binders function as agonists, antagonists, or targeting moieties in drug discovery and therapeutic development, offering high-affinity, sequence-defined DNA/RNA aptamers for precise engagement of biomolecular targets
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Aptamer Group
Novoheart
HQ: Canada
Website
- Description: Provider of stem cell and bioengineering platforms and services for cardiac drug discovery, including the MyHeart/mini-Heart Platform of engineered human cardiomyocyte tissues for assessing cardiac functional outputs in pre-clinical and clinical trials; the Human Heart-in-a-Jar (hvCOC); hvCAS for electrophysiology, arrhythmia, contractility and pressure-volume; the mini-Life multi-organ system; and custom drug discovery, cardiotoxicity screening, disease modeling, efficacy and dose titration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Novoheart company profile →
Cryoniss
HQ: United Kingdom
Website
- Description: Provider of temperature-controlled biobanking and cold-chain logistics for life sciences, offering regulated storage of human biological samples at vapour phase liquid nitrogen, -80°C, -20°C, +4°C and ambient; cell banking and culture with next-day dispatch; bioreagents storage with cloud-based traceability; cell line QC testing via preferred suppliers; end-to-end sample transport; and access to samples for research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cryoniss company profile →
Pressure BioSciences
HQ: United States
Website
- Description: Provider of proprietary laboratory instrumentation and consumables: Pressure Cycling Technology (PCT) for controlled biomolecular interactions (cell lysis, biomolecule extraction) in biomarker discovery, drug design and forensics; BaroFold for high-pressure protein disaggregation/refolding to remove aggregates and enhance product safety and efficacy; and Ultra Shear Technology (UST) to make stable nanoemulsions, improving solubility and stability.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pressure BioSciences company profile →
Enlight Biosciences
HQ: United States
Website
- Description: Provider of technology platforms and software, including Entrega for enabling oral delivery of complex biological molecules and drug substances, KNODE for connecting users with experts and their content within and beyond R&D organizations, and Peerin, a Twitter application that helps professionals discover industry-specific insights by identifying and ranking high-value conversations and trends.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enlight Biosciences company profile →
Glympse Bio
HQ: United States
Website
- Description: Provider of noninvasive, predictive diagnostic solutions for monitoring multiple human diseases, using precisely engineered diagnostic agents that interrogate the body for disease states and carry the message to the urine for analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Glympse Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Aptamer Group
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Aptamer Group
2.2 - Growth funds investing in similar companies to Aptamer Group
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Aptamer Group
4.2 - Public trading comparable groups for Aptamer Group
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →